Merck & Co. Inc. (MRK)
-NYSE 45.86 
0.17(0.37%) 1:03PM EDT - Nasdaq Real Time Price
| Prev Close: | 45.69 |
|---|
| Open: | 45.90 |
|---|
| Bid: | 45.88 x 7000 |
|---|
| Ask: | 45.89 x 6300 |
|---|
| 1y Target Est: | 50.43 |
|---|
| Beta: | 0.38 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 45.49 - 46.01 |
|---|
| 52wk Range: | 37.02 - 48.79 |
|---|
| Volume: | 7,801,020 |
|---|
| Avg Vol (3m): | 16,718,600 |
|---|
| Market Cap: | 138.69B |
|---|
| P/E (ttm): | 22.94 |
|---|
| EPS (ttm): | 2.00 |
|---|
| Div & Yield: | 1.72 (3.60%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Featured on Yahoo! Finance
Headlines
- 3 Blue Chips with Big Buyback Plansat Motley Fool(Thu 12:33PM EDT)
- Mapping Merck: Q1 And Beyondat Seeking Alpha(Thu 12:02PM EDT)
- Gilead reports positive test results from hepatitis C treatment studiesat MarketWatch(Thu 10:56AM EDT)
- US STOCKS-Wall Street gains on data, ECB rate cutat Reuters(Thu 10:26AM EDT)
- US STOCKS-Wall Street set to open slightly higher on data, ECB cutat Reuters(Thu 9:13AM EDT)
- Company News for May 2, 2013Zacks(Thu 8:45AM EDT)
- US STOCKS-Futures extend gains after ECB rate cutat Reuters(Thu 8:18AM EDT)
- US STOCKS-Futures gain ahead of ECB rate decisionat Reuters(Thu 7:24AM EDT)
- Dow Falls on Employment Worriesat Motley Fool(Wed, May 1)
- Merck & Co Earnings Call Nuggets: PD-1 Program and Share Repurchasesat Wall St. Cheat Sheet(Wed, May 1)
- Merck Lowers 2013 Guidanceat Motley Fool(Wed, May 1)
- [video] No Huddle Offense: Profits In the Pipeline?at CNBC(Wed, May 1)
- [video] Am I Diversified? Cramer's Callat CNBC(Wed, May 1)
- An Animal of a Quarterat Motley Fool(Wed, May 1)
- Stocks sink on economic worries; Dow off 138AP(Wed, May 1)
Key Statistics
| Forward P/E (1 yr): | 11.98 |
|---|
| P/S (ttm): | 2.92 |
|---|
| Ex-Dividend Date: | 13-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.63 |
|---|
| Quarterly EPS Est
(Mar-13)
: | 0.79 |
|---|
| Mean Recommendation*: | 2.2 |
|---|
| PEG Ratio (5 yr expected): | 3.07 |
|---|
Business Summary
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide.
View More